News

The French EyeOP1 medical device, from EyeTechCare, is a novel and non-invasive treatment for glaucoma that is based on the use of high-intensity focused ultrasound (HIFUs). The product is set to become available at the end of 2010

The merger Novartis has been trying to unilaterally impose on Alcon cannot go ahead without the approval of Alcon's Independent Director Committee (IDC), according to a legal expert

Ophthalmic instrument and replacement lens business, Ophtec BV, has expanded its business into the Far East with a site based in Japan.

Scientists in The Netherlands have received an innovation grant to finalise the specification of a collagen, derived from fishscale, which will act as an alternative material for cornea regeneration.

President of the Middle East African Council of Ophthalmology (MEACO), Dr Abdulaziz Al Rajhi, is to become president of the World Ophthalmology Congress (WOC) 2012.

Dr Joachim Storsberg at the Fraunhofer Institute for Applied Polymer Research in Germany has developed an artificial cornea. The ophthalmological polymer is designed to bond to the eye but remain unclouded by cells in its centre.

Alcon Inc. is to sponsor a four-week ophthalmic skills exchange and surgical programme through ORBIS International?s signature Flying Eye Hospital.

France Lens has launched, The Concept Asphilens 1.8, a new aspheric implant specifically designed for microincision cataract surgery (MICS).

As part of last week's National Eye Health Week in the UK, Spectrum Théa, the independent ophthalmic company, looked at things from a patient's perspective.

The Pediatric Cataract Initiative ( ), sponsored by the Bausch + Lomb Early Vision Institute and Lions Clubs International Foundation, has announced its inaugural global advisory council.

Fight for Sight, a UK leading eye research charity, has awarded two new grants totalling £350,000 for research into glaucoma ? one of the leading causes of preventable blindness in the UK

In a sample of moderate evaporative-type dry eye disease patients Enriquez-de-Salamanca et al., elevated five inflammatory molecules. Fracktalkine was demonstrated to be present and elevated in tears in human DED.

Imprinting tiny brand logos and providing miniaturized functional inscriptions on hard and transparent high value parts such as eye glass lenses and diamonds requires a material-friendly and high-resolution marking and engraving tool. The short 193nm pulses of excimer lasers eliminate the widely-known problems of cracking and melting which are due to thermal load effects of longer wavelength lasers. The low optical penetration depth of the 193nm wavelength in diamond, glass and plastic substrates prevents bulk heating and delivers cold and precise marks and engravings on a micron scale and in optically transparent material.

A new disinfecting technology for soft contact lenses from Abbott has received European regulatory approval. Complete RevitaLens Multipurpose Disinfecting Solution was developed in partnership with the Holden Vision Institute.

This year's highly prestigious Champalimaud Vision Award is shared between two worthy winners for their ground-breaking research in neuroscience and how the brain contructs images.

Carl Zeiss Meditec presented its expanded offering of ophthalmic solutions at this year's WOC 2010 in Berlin.

Optimax has refined its Intralase technology to introduce what it calls 'unprecedented' levels of control for its surgeons through the rollout of the new generation iFS IntraLase Lasers across its UK clinics.

OTE Editorial Advisory Board Member, Professor Gisele Soubrane has become the first woman to receive an International Council of Ophthalmology (ICO) medal.

Retinal imaging company, Optos Plc having made a return to profitability is taking its Optomap Retinal Exam to the ophthalmology community and had a strong presence at this year?s WOC in Berlin.

In his presentation at the World Ophthalmology Congress, Dr Matthew Benz highlighted that the first Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) had met its primary endpoint with 27.7% of the 220 microplasmin treated patients achieving resolution of their VMA at 1 month, compared to 13.2% of the 106 patients who received a placebo injection, a highly statistically significant result (p=0.003).

Dr Naveed Shams has been appointed as the new vice president of clinical affairs at Santen Pharmaceutical Co., Ltd.

NCX 434, a new drug candidate form NicOx, is reported to improve oxygen saturation in the eye and preclinical data was recently presented at the Ocular Diseases & Drug Discovery Conference

Developed by US ophthalmologists, the surgical procedure DSAEK (Descemet's Stripping Automated Endothelial Keratoplasty) is increasingly being employed in German eye clinics too.

A team of scientists at UC Irvine (UCI) in California have taken the first step in developing transplant-ready retinas by creating an eight-layer, early-stage retina from human embryonic stem cells.

The European Uveitis Patient Association will present an award to Dr Richard Lee, NIHR clinical lecturer in ophthalmology at the University of Bristol at the forthcoming WOC for his recent research paper

We are pleased to notify you of a groundbreaking event : the very first live DSAEK surgery transmitted on the web.

Clinicians pose several arguments for trabeculectomy and tube-shunt surgery

Piecewise linear regression methods define structure-function relationship in glaucoma

Surgeon says efficacy, safety, predictability results being achieved are impressive

Come and visit the Bausch + Lomb Booth No 16 at the WOC in Berlin to meet the Experts and ask questions. Explore Q2, delivering Quantity and Quality of Vision with the revolutionary Crystalens HD?, the premium accommodating IOL that gives high definition vision at all distances.